Ruptureable, dual reagent mono-capsules are disclosed that have a core composition, which includes a first reagent, encapsulated within a polymer wall, and a shell connected to an exterior surface of the polymer wall by a surfactant. The shell is made from a second reagent that is chemically bonded to the surfactant by a chemical electrostatic interaction. Upon rupture of the polymer wall of the mono-capsule, the first reagent and the second reagent chemically react with one another to form a reaction product.

The present invention relates to a process for preparing a modified wood product wherein a step of resin treatment is followed by a thermal modification step. The present invention also relates to a modified wood product produced using said process.

Processes for the manufacture of thermally curable resins contain the step of the reaction of a polycondensation-capable phenolic compound and/or of an aminoplastic forming agent with 5-hydroxymethylfurfural (HMF) under conditions leading to formation of polycondensation products. The HMF includes at least one HMF oligomer. Further, thermally curable resins produced by such processes may be used for the manufacture of a wood composite material.

A process for the manufacture of wood composite materials includes the steps of: preparation of a thermally curable resin by reacting a polycondensation-capable phenolic compound and/or an amino plastic forming agent with 5-hydroxymethylfurfural (HMF) under conditions leading to the formation of polycondensation products, bringing the resin into contact with lignocellulose-containing material, and curing the resin with formation of the wood composite material. The 5-hydroxymethylfurfural includes at least one HMF oligomer. Further, wood composite materials are obtainable by the process.

The present invention relates to a condensation product, obtained or obtainable by the reaction of phenol, formaldehyde, sulfuric acid and urea, or a pharmaceutical composition comprising the same for use in a method for the prevention or treatment of Coronavirus disease 2019 (COVID-19) and/or for the prevention or treatment of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection, to a pharmaceutical set comprising such a pharmaceutical composition for the same use and to such a pharmaceutical composition or pharmaceutical set.

The present invention relates to a condensation product, obtained or obtainable by the reaction of phenol, formaldehyde, sulfuric acid and urea, or a pharmaceutical composition comprising the same for use in a method for the prevention or treatment of Coronavirus disease 2019 (COVID-19) and/or for the prevention or treatment of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection, to a pharmaceutical set comprising such a pharmaceutical composition for the same use and to such a pharmaceutical composition or pharmaceutical set.

This application relates to the field of battery technologies, and in particular, to a binder and a preparation method thereof, and a separator, electrode assembly, battery cell, battery, and electric apparatus containing such binder. The binder includes a capsule and a core material provided in the capsule, where the capsule includes an organic polymer, and the core material includes a plasticizer. The plasticizer is encapsulated as the core material inside the capsule of the organic polymer to improve adhesion performance of the organic polymer, so as to increase adhesion force between a separator and an electrode plate by the binder.

Microcapsules are disclosed that have a core composition encapsulated within a polymer wall, and an inorganic shell connected to an exterior surface of the polymer wall by a surfactant. The inorganic shell has a cation attracted to the surfactant and an anion or anion equivalent chemically bonded to the cation to form the shell or has the metal portion of a metal-containing compound attracted to the surfactant to form the shell. The shell may comprise a Ca, Mg, or Ag metal compound. The shell may be a graphene oxide-metal compound.

The present application is directed to methods for solvent-free preparation of polymers and their subsequent processing into activated carbon materials. These methods unexpectedly demonstrate ability to tune pore structure in the polymer gel and carbon produced there from, while also providing distinct advantages over the current art.

The present application is directed to methods for solvent-free preparation of polymers and their subsequent processing into activated carbon materials. These methods unexpectedly demonstrate ability to tune pore structure in the polymer gel and carbon produced there from, while also providing distinct advantages over the current art.